[1] STERNS RH. Causes of hypotonic hyponatremia in adults[EB/OL]. (2022-07-25)[2023-11-04]. http://www-uptodate-cn-s.vpn.lib.zryhyy.com.cn:8118/contents/causes-of-hypotonic-hyponatremia-in-D%8E%E9%92%A0%E8%A1%80%E7%97%87&source=Out%20of%20date%20-%20zh-Hans&selectedTitle=3~150. [2] LIAMIS G, MEGAPANOU E, ELISAF M, et al.Hyponatremia-inducing drugs[J]. Front Horm Res, 2019, 52: 167-177. [3] WANG MQ.Hyponatraemia induced by the application of omeprazole[J]. Chinese Journal of Pharmacoepidemiology(药物流行病学杂志), 1995, 4(4): 205. [4] SHIBA S, SUGIURA K, EBATA A, et al.Hyponatremia with consciousness disturbance caused by omeprazole administration: a case report and literature review[J]. Dig Dis Sci, 1996, 41(8): 1615-1617. [5] BEBARTA VS, KING JA, MCDONOUGH M. Proton pump inhibitor-induced rhabdomyolysis and hyponatremic delirium[J]. Am J Emerg Med, 2008, 26(4): 519. e1-e2. [6] VAN DER ZALM IJB, TOBÉ TJM, LOGTENBERG SJJ. Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report[J]. J Med Case Rep, 2020, 14(1): 83. [7] QURESHI AS, QUADRI MA, JAVED B.Unusual neurological manifestation of proton pump inhibitor: a case report of acute disseminated encephalomyelitis and severe hyponatremia after brief use of proton pump inhibitor[J]. Cureus, 2021, 13(6): e15571. [8] PAUL LP, MARTIN J, BUON M, et al.Nouvel effet indésirable fréquent des inhibiteurs de la pompe à protons chez le sujet âgé : l'hyponatrémie modérée[J]. Therapie, 2014, 69(2): 157-162. [9] HEITZMANN D, WARTH R.No potassium, no acid: K+ channels and gastric acid secretion[J]. Physiology (Bethesda), 2007, 22: 335-341. [10] ISSA I, SKOV J, FALHAMMAR H, et al.Time-dependent association between omeprazole and esomeprazole and hospitalization due to hyponatremia[J]. Eur J Clin Pharmacol, 2023, 79(1): 71-77. [11] FERREIRA F, MATEUS S, SANTOS AR, et al.Pantoprazole-related symptomatic hyponatremia[J]. Eur J Case Rep Intern Med, 2016, 3(2): 000341. [12] FALHAMMAR H, LINDH JD, CALISSENDORFF J, et al.Associations of proton pump inhibitors and hospitalization due to hyponatremia: a population-based case-control study[J]. Eur J Intern Med, 2019, 59: 65-69. [13] EL-ALALI E, AL JABER E.Association of proton pump inhibitor use and significant hyponatremia-a US population-based case-control study[J]. Proc (Bayl Univ Med Cent), 2022, 35(4): 434-436. [14] Pharmgkb. Omeprazole[EB/OL].[2023-11-04]. https://www.pharmgkb.org/chemical/PA450704/clinicalAnnotation. [15] Pharmgkb. Annotation of CPIC Guideline for lansoprazole, omeprazole, pantoprazole and CYP2C19[EB/OL].[2023-11-04]. https://www.pharmgkb.org/guidelineAnnotation/PA166219103. [16] Medicine, N.L.o. Reference SNP (rs) Report[EB/OL]. (2022-09-21)[2023-11-04]. https://www.ncbi.nlm.nih.gov/snp/rs4244285. [17] HU XP, XU JM, HU YM, et al.Effects of CYP2C19 genetic polymorphism on the pharmacokinetics and pharmacodynamics of omeprazole in Chinese people[J]. J Clin Pharm Ther, 2007, 32(5): 517-524. [18] JEU L, PIACENT FJ, LYAKHOVETSKIY AG, et al.Voriconazole[J]. Clin Ther, 2003, 25(5): 1321-1381. [19] Lexicomp. Isavuconazonium Sulfate (Lexi-Drugs Multinational)[EB/OL].[2023-11-04]. https://online.lexi.com/lco/action/doc/retrieve/docid/multinat_f/5561473?cesid=1q0H8gRYH4l&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3DIsavuconazonium%26t%3Dname%26acs%3Dfalse%26acq%3DIsavuconazonium#cyt. |